UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Blood, 2020-11, Vol.136 (20), p.2334-2345

2020

Volltextzugriff (PDF)

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways

Leukemia, 2021-01, Vol.35 (1), p.177-188

2021

Volltextzugriff (PDF)

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

International journal of hematology, 2022-02, Vol.115 (2), p.233-243

2022

Volltextzugriff (PDF)

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8529-8539

2022

Volltextzugriff (PDF)

Overexpression of miR-669m inhibits erythroblast differentiation

Scientific reports, 2020-08, Vol.10 (1), p.13554-13554, Article 13554

2020

Volltextzugriff (PDF)

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Nature communications, 2024-02, Vol.15 (1), p.1367-1367, Article 1367

2024

Volltextzugriff (PDF)

Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia

Annals of hematology, 2021-10, Vol.100 (10), p.2479-2486

2021

Volltextzugriff (PDF)

A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor

International journal of hematology, 2021-04, Vol.113 (4), p.606-610

2021

Volltextzugriff (PDF)

Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies

International journal of hematology, 2023-04, Vol.117 (4), p.553-562

2023

Volltextzugriff (PDF)

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement

Journal of Clinical and Experimental Hematopathology, 2020, Vol.60(2), pp.60-61

2020

Volltextzugriff (PDF)

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-09, Vol.28 (9), p.1279-1285

2022

Volltextzugriff (PDF)

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report

Leukemia research reports, 2024, Vol.22, p.100478, Article 100478

2024

Volltextzugriff (PDF)

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement

Journal of Clinical and Experimental Hematopathology, 2020-06, Vol.60 (2), p.60-61

2020

Volltextzugriff (PDF)

Chédiak–Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia

International journal of hematology, 2016-12, Vol.104 (6), p.637-638

2016

Volltextzugriff (PDF)

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

Journal of Clinical and Experimental Hematopathology, 2020, Vol.60(4), pp.159-168

2020

Volltextzugriff (PDF)

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia

International journal of hematology, 2017-12, Vol.106 (6), p.811-819

2017

Volltextzugriff (PDF)

Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma

Cancer science, 2016-09, Vol.107 (9), p.1281-1289

2016

Volltextzugriff (PDF)

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

Blood cancer journal (New York), 2023-02, Vol.13 (1), p.23-23, Article 23

2023

Volltextzugriff (PDF)

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma

Journal of Clinical and Experimental Hematopathology, 2019, Vol.59(1), pp.34-39

2019

Volltextzugriff (PDF)

Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma

Blood cancer discovery, 2021-07, Vol.2 (4), p.370

2021

Volltextzugriff (PDF)

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

Journal of Clinical and Experimental Hematopathology, 2020-12, Vol.60 (4), p.159-168

2020

Volltextzugriff (PDF)

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma

Journal of Clinical and Experimental Hematopathology, 2019-04, Vol.59 (1), p.34-39

2019

Volltextzugriff (PDF)

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

International journal of hematology, 2016-03, Vol.103 (3), p.341-347

2016

Volltextzugriff (PDF)

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

Leukemia research reports, 2016, Vol.5 (C), p.11-13

2016

Volltextzugriff (PDF)

Identification a Novel Molecular Mechanism Underlying the Anti-CD38-Based Treatment Resistance in Multiple Myeloma Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.2081-2082

2022

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(58)
Berichte
(2)

Sprache

Englisch
(53)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(25)
Humans
(24)
Hematology
(22)
Oncology
(18)
Medicine
(12)
Medicine & Public Health
(11)
Middle Aged
(11)
Male
(10)
Female
(9)
Aged
(8)
Multiple Myeloma
(8)
Adult
(7)
Aged, 80 And Over
(6)
Multiple Myeloma - Drug Therapy
(6)
Original Article
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Epstein-Barr Virus
(5)
Kinases
(5)
Leukemia
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma

Overexpression of miR-669m inhibits erythroblast differentiation

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia

A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor

Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement

Chédiak–Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia

Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma

Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions

A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report

Identification a Novel Molecular Mechanism Underlying the Anti-CD38-Based Treatment Resistance in Multiple Myeloma Patients

Suchergebnisse filtern